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OBJECTIVES We report on the early and intermediate-term follow-up results of self-expanding Wallstent
(Schneider, Switzerland) implanted in children with congenital heart disease.
BACKGROUND The inherent shortcomings of balloon-expandable stents prompted the trial of an alternative
stent.
METHODS Twenty patients underwent 22 implantations of 25 self-expanding Wallstents between
December 1993 and June 1997 in two institutions. The mean age and weight were 10.8 6
4.5 years and 30.5 6 14.2 kg, respectively. The patients were divided into two groups: 1)
Group I comprised 17 patients with pulmonary arterial stenoses, 2) Group II comprised four
patients with venous stenoses (one belonged to both groups). Sixteen patients underwent
recatheterization at a median of 5.8 months (range 0.5 to 31, mean 8.1 months) after stenting.
Hemodynamic and angiographic changes after the interventional procedures and complica-
tions were documented.
RESULTS All the stents were successfully deployed in the intended position. In Group I, the narrowest
diameter of the stented vessel increased from 4.1 6 1.5 to 8 6 2 mm (95% increase, p ,
0.0001) while the systolic pressure gradient across decreased from 24.6 6 15.8 to 12.1 6
11.4 mm Hg (51% decrease, p 5 0.001). In Group II, the dimensional changes of the
narrowest segment increased from 4.3 6 0.5 to 7.5 6 0.4 mm (75% increase, p 5 0.003), and
the pressure gradient reduced from 5.0 6 2.9 to 0.9 6 1.0 mm Hg (82% decrease, p 5 0.04)
across the stented venous channel. Distal migration of two optimally positioned stents
occurred within 24 h of implantation. At recatheterization, significant neointimal ingrowth
(.30% of the expanded diameter) was noted in 7 (28%) of the 25 implanted stents. This
responded poorly to balloon dilation. Predisposing factors for the neointimal ingrowth
included stents of smaller diameter (,9 mm) and longer period after implantation.
CONCLUSIONS Self-expanding Wallstent could be deployed easily and safely to relieve vascular stenoses in
children. The complications of distal migration, significant neointimal ingrowth and its
unyielding design to overdilation limit its application to this patient group. (J Am Coll
Cardiol 2000;35:1007–15) © 2000 by the American College of Cardiology
In the management of congenital heart disease, balloon-
expandable stents have been used with success for obstructive
vascular lesions that tend to recoil after dilatation (1–4). The
use of self-expanding stents was subsequently applied to this
group of children (5,6). These stents have the advantages of
requiring a smaller sheath for introduction, a longer length for
placement across long stenotic segments and decreased risk of
embolization by premounting the stent onto the catheter. The
inherent risk of balloon rupture with incomplete stent expan-
sion described during deployment of Palmaz stents (7) could be
avoided and placement in tortuous vessels facilitated. Reports
on its application, however, have been limited to preliminary
experience and short-term benefits (5,6). Attracted by the ease
of utilization and accurate placement of such stent, our group
from two institutions has applied it to a number of children
with congenital heart disease. We report the early and
intermediate-term follow-up results.
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METHODS
Patients. Between December 1993 and June 1997, 25
self-expanding Wallstents (Schneider, Switzerland) were
placed in 20 patients. Ten were treated at Grantham
Hospital, University of Hong Kong, while the remainder
were treated at British Columbia’s Children’s Hospital,
Vancouver, Canada. Their mean age and weight were
10.8 6 4.5 years and 30.5 6 14.2 kg, respectively. The
patients were divided into two groups (Table 1). Group I
comprised 17 patients with pulmonary arterial stenoses.
One had concomitant narrowing extending up the Goretex
tube (WL Gore & Associates, Flagstaff, Arizona) of the
modified left Blalock-Taussig shunt. Group II comprised
four patients with obstruction of the systemic venous
drainage. One patient belonged to both groups.
Indications. Branch pulmonary arterial stenoses were con-
sidered significant in the presence of exercise intolerance,
clinical evidence of right heart failure or echocardiographic
features of right ventricular dysfunction. Transcatheter in-
tervention was the initial management of choice. Endovas-
cular stenting was attempted when the expandable arterial
and venous stenoses recoiled after balloon angioplasty.
Self-expanding Wallstents were chosen in the following
situations: a tortuous course to the site of stenosis where
passage of the long delivery sheath for balloon dilatable
Palmaz (Johnson & Johnson, Cordis USA) stents were
judged to be difficult, long-segment hypoplasia and stenosis
and unsuccessful attempts of Palmaz stent placements.
Significant systemic desaturation (,60%) was the major
indicator for stenting in a patient with pulmonary atresia,
ventricular septal defect and disconnected pulmonary arter-
ies. Previous multiple surgical revisions of the modified
Blalock-Taussig shunts on both sides failed to improve the
size of the pulmonary arteries, and the parents were reluc-
tant to agree to the relative high risk total correction.
Balloon dilatation of the stenosed shunt and the pulmonary
artery at the anastomosis had an initial successful result, but
the narrowing recurred.
Methods. Balloon dilatations were performed in all pa-
tients with the accepted standard protocol. This served to
ascertain that the stenoses were dilatable and to break the
fibrotic tissue prior to stent implantation. The self-
expanding Wallstent was then placed according to the
method described previously (5). The size of the stent was
chosen such that close approximation to the vessel proximal
and distal to the stenosis was achieved. The ratio of the size
of stent to the diameter of stenoses was 2.9 6 1.1. The
length of the stent was between 20 to 56 mm (mean 5
36 mm). Mild hourglass appearance was common after
complete deployment, and this was accepted. In two pa-
tients, moderate hourglass deformity (a reduction of more
than 15% of the diameter) of the expanded stent was
present. This was abolished by dilation using a balloon of
size equal to the diameter of the fully expanded stent.
Of the 22 implantation procedures performed, 20 were
under general anesthesia and 2 under local anesthesia. The
mean procedural and fluoroscopic times were 181 6 66 and
52 6 26 min, respectively (this excluded one patient who
had a 5-h procedure due to the embolization of the initially
deployed Palmaz stent and requiring subsequent implanta-
tion of a Wallstent). Systemic heparinization was given in
all but three procedures. Oral aspirin or warfarin was given
for three months after the stent implantation. For patients
after Fontan operation, oral warfarin was continued beyond
three months.
The hemodynamic and angiographic changes were doc-
umented before and immediately after stenting and on
follow-up catheterization. The diameter of the stenotic
segment was measured using the catheter size as the
magnification factor (Grantham Hospital) or isocentric
magnification correction at standard image intensifier
height (British Columbia’s Children’s Hospital). The sys-
tolic and mean pressure gradients across the arterial and
venous stenoses were assessed, respectively. The systolic
right ventricular pressure and the simultaneous systemic
systolic blood pressure for those who had right ventricular
outflow tract reconstruction and pulmonary arterial stenoses
were documented. Significant neointimal ingrowth was
Table 1. Indications for Implantation of Self-Expanding
Wallstents
Cardiac Diagnosis
No. of
Patients
No. of
Stents
Group I: Pulmonary Arterial
Stenoses (n 5 17)
Post-RVOTR 16
PAVSD 7
TOF 5
PAIVS 1
Post-Fontan operation 3
DORV, TGA, unbalanced AVSD 1
PAVSD, TGA, hypoplastic RV 1
DILV, TGA, subaortic
stenosis and CoA
1*
Palliative Shunting 1
PAVSD, disconnected
pulmonary arteries, bilateral
modified Blalock-Taussig shunts
1
Group II: Venous Stenoses (n 5 4)
TGA, post-Mustard operation SCV-
baffle stenosis
2 2
Right SCV stenosis postcardiac
transplant
1* 1
Left SCV stenosis postrepair of CoA
and arch reconstruction
1 2
*This patient developed severe protein losing enteropathy after Fontan operation and
underwent cardiac transplantation.
AVSD 5 atrioventricular septal defect; CoA 5 coarctation of aorta; DILV 5
double-inlet left ventricle; DORV 5 double-outlet right ventricle; PAIVS 5
pulmonary atresia with intact ventricular septum; PAVSD 5 pulmonary atresia with
ventricular septal defect; RV 5 right ventricle; RVOTR 5 right ventricular outflow
tract reconstruction; SCV 5 superior caval venous; TGA 5 transposition of great
arteries; TOF 5 tetralogy of Fallot.
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arbitrarily defined as reduction of more than 30% of the
luminal diameter, which corresponded to a decrease of more
than 50% of the cross-sectional area (cross-sectional area 5
pi 3 diameter2/4). Early and late complications were noted.
Sixteen (80%) patients were recatheterized at a median
duration of 5.8 months (range 0.5 to 31, mean 5 8.1
months) after the initial stent placement. Fourteen patients
belonged to Group I, and three to Group II (including one
who belonged to both groups).
Statistics. The changes in diameter of the stenosis, pres-
sure gradient across the stenotic segment, systolic right
ventricular pressure and ratio of systolic right ventricular to
systemic systolic pressure before and after stent implantation
and at the time of restudy were compared using paired,
two-tailed Student t test. Univariate analysis of possible risk
factors contributing to significant neointimal growth was
performed using the paired Student t test and chi-square
test where appropriate. The results were expressed as
mean 6 standard deviation, unless otherwise stated. Statis-
tical significance was set at 5%.
RESULTS
Early results. Group I (pulmonary arterial stenoses). All the
premounted catheters could be negotiated across the steno-
ses with successful deployment of the 20 stents. The
diameter of the stenosed vessel increased from 4.1 6 1.5 to
8 6 2 mm after stent implantation (95% increase, p ,
0.0001) (Fig. 1A). The pressure gradient across the stenotic
segment was reduced from 24.6 6 15.8 to 12.1 6
11.4 mm Hg (51% decrease, p 5 0.001) (Fig. 1B). For
patients whose right ventricle supported the pulmonary
circulation, there was no significant change in the absolute
right ventricular pressure or its ratio to the systemic pressure
(Fig. 1C). This was attributed to the relative small number
of patients and the concomitant stenotic lesions often
present in other parts of the pulmonary arterial tree. The
patient with the concomitant stenosed modified left
Blalock-Taussig shunt had immediate improvement of her
systemic oxygen saturation from 58% to 73%.
Group II (venous stenosis). Five Wallstents were placed
optimally across all the venous stenoses. The diameter of the
stenosed venous pathways increased from 4.3 6 0.5 to 7.5 6
0.4 mm (75% increase, p 5 0.003) after stent implantation.
The mean pressure gradient across the stenoses was reduced
from 5 6 2.9 to 0.9 6 1 mm Hg (82% decrease, p 5 0.04).
Complications. Distal migration of the stents occurred in
two patients. One had a long segment stenosis of the left
pulmonary artery after total correction of tetralogy of Fallot.
A Wallstent of 8 mm in diameter was placed across the
3.3 mm stenotic segment, and mild hourglass appearance of
the expanded stent was noted. Despite optimal positioning,
routine chest roentgenogram at 24 h after the implantation
revealed distal migration of the stent (Fig. 2, A and B). The
systolic pressure gradient before and after stent implantation
in this patient appeared higher than those of nonmigrated
stents placed in pulmonary arteries after previous right
ventricular outflow tract reconstruction (preimplantation:
50 vs. 27.1 6 13.7 mm Hg, postimplantation: 30 vs. 10.5 6
8.5 mm Hg, p , 0.001 in both situations). At the second
stenting procedure, the migrated stent was pushed further
distally during manipulation of the catheter and guidewire.
Instead of the intended overlapping of the two stents, a
small gap between the facing ends of the two stents was
inadvertently introduced.
The second patient had a previous Mustard operation
with superior caval venous baffle stenosis. Its caliber tapered
from 8 mm to 5 mm. Despite initial optimal positioning, a
12-mm stent migrated into the left atrium and encroached
upon the mitral valve on the day after stent implantation
(Fig. 2, C and D). This required urgent operative removal.
In both cases, the diameter of the stent was 2.4 times that
of the narrowest segment. This ratio did not differ from
those of the patients whose stent did not experience distal
migration (2.8 6 1.2, p 5 0.63).
Bilateral brachial plexus palsy occurred in a patient with
left pulmonary arterial stenosis after surgical correction of
tetralogy of Fallot. The initial attempt to deploy a Palmaz
stent was complicated by migration of the stent to the distal
left pulmonary artery before full expansion was achieved.
Further manipulation of the sheath across the stenosis
proved unsuccessful. Delivery and deployment of a Wall-
stent over the guidewire was accomplished with ease. The
whole procedure lasted 5 h and 15 min. The patient
recovered completely after three months of physiotherapy.
Follow-up. The patients were followed up for a median of
14.8 months (range 0.3 to 42 months). The results of the
cardiac catheterization restudies are shown in Table 2.
Comparing with the immediate poststenting status, the
stented pulmonary arteries and venous pathways showed
insignificant decrease in the luminal diameter (p 5 0.075
and 0.15, respectively). The increase in pressure gradient
across the arterial stenoses was significant (p 5 0.02) in
contrast to the insignificant increase across the venous
stenoses (p 5 0.33). For patients with right ventricular
outflow tract reconstruction and stenting of the stenosed
pulmonary arteries, there was no significant drop of the
right ventricular pressure noted on follow-up.
Significant intimal proliferation, defined as .30% reduc-
tion of the expanded luminal diameter, occurred in seven
stents: five implanted in pulmonary arteries (Fig. 3), one
each in the left superior caval vein and the modified left
Blalock-Taussig shunt. One stent implanted in the upper
lobe branch of the right pulmonary artery was completely
occluded. As for the other stents, neointimal proliferation
occurred in the midportion or proximal end of the stents.
The patient who required a second Wallstent implantation,
after distal migration of the first deployed self-expandable
stent, had the most severe neointimal ingrowth. Its thick-
ness amounted to 40% of the stented luminal diameter. The
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Figure 1. Line plots showing: (A) the increase in diameters of the pulmonary arterial stenosis and (B) decrease in systolic pressure gradients
before and immediately after implantation of self-expanding Wallstents. For patients with a functional right ventricle, no significant
change of the right ventricular to the systemic systolic pressure ratio could be documented (C). Figure 1, part C on facing page.
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proliferation was maximal at the gap in between the facing
ends of the two stents, extending proximally to involve the
midportion of the newly placed stent. The stented modified
Blalock-Taussig shunt had irregular heaping of the intima
at the proximal and distal ends of the stent. The risk factors
associated with significant neointimal proliferation were a
smaller diameter of the stents (p 5 0.01) and longer period
after implantation (p 5 0.04) (Table 3). Angiographically,
there was no evidence of any disturbance of blood flow to
the side branches that the stents crossed. The migrated stent
in the distal left pulmonary artery was free of excessive
intimal coverage, and blood flow to the distal branches was
not jeopardized.
Balloon dilation was attempted in six stented vessels with
significant neointimal proliferation. In five, the diameter
increased from 4.4 6 1.6 to 5.9 6 1.4 mm (p 5 0.0004).
This amounted to 83% of the initial stented luminal size.
Unsatisfactory balloon angioplasty for the restenosis of a
stented left superior caval vein prompted the placement of a
balloon expandable Palmaz stent and a second Wallstent at
either end of the caval vein, with considerable overlapping
of the stents. The completely occluded stent was treated
conservatively.
DISCUSSION
Immediate results. Self-expanding Wallstent has been
extensively used in Europe for adult patients with iliac and
femoral arterial stenoses (8,9) and malignant caval venous
obstruction (10). Reports on the use of self-expandable
stents in children with congenital heart disease are limited,
and intermediate term follow-up results are lacking (5,6).
Most other publications on stenting of stenosed vessels in
children were relating to the experience on balloon-
expandable Palmaz stents (1–4).
The immediate results after Wallstent implantation were
impressive. Implantation of these self-expandable stents in
an optimal position was feasible in all the patients. The
ability to pull the partially deployed Wallstent proximally
allows for exact placement across the narrowest segment.
Optimal positioning of Palmaz stents was reported to be
possible in 95% to 96% of the patients (1–3), but it was
unclear how many procedures were abandoned as a result of
failure to pass the large-bore sheath through a tortuous
stenotic passage. The ease of delivery and position of the
Wallstent over the guidewire is an obvious advantage over
the Palmaz stent. The significant increase in the diameter of
stenoses and the decrease in pressure gradient parallel that
of the experience of the Palmaz stent (1,2,7). Once fully
expanded, however, both types of stents could not be
retrieved by transcatheter techniques. Our results attest to
the efficacy of Wallstents in relieving stenotic lesions in
congenital heart disease.
Early complications. This gratifying result was, however,
undermined by the occurrence of delayed migration of two
optimally positioned stents (one from each center). A
Figure 1. Continued
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similar event had been described after Wallstent implan-
tation for the treatment of malignant superior caval
venous stenosis (11) but has not been reported with the
use of Palmaz stent. The cause of the delayed migration
could only be speculative at this stage. In contrast with
the more flexible Wallstent, the rigidity of Palmaz stent
after balloon expansion could resist the compressive
forces of the expanded stenotic lesion, and this probably
prevents any delayed migration. Furthermore, the radial
force of expansion exerting on different portions of the
stented vessel may differ when self-expansion of the stent
is incomplete (12). With gradual increase in the diame-
ter, the radial force decreases and development of eccen-
tric radial force due to unequal rate of expansion may
propel the stent to migrate in either direction. “Fixing”
the Wallstent by balloon dilatation after deployment may
perhaps reduce the risk of migration. Since delayed
migration could result in restenosis or the stent encroach-
Figure 2. Chest roentgenograms showing the initial optimal position and subsequent distal migration of the Wallstents implanted in a
hypoplastic left pulmonary artery (A and B). Note the change in position and shape of the proximal end of the stent before and after
migration (arrow). In another patient with superior caval venous baffle stenosis, anterioposterior projection of radiography showing initial
optimal position of the deployed stent for stenosed baffled limb (C). Note the relative position of the stent in relation to the vertebral
border. Chest roentgenogram the next morning showed the stent had migrated, with significant alteration of its alignment and relative
position to the vertebral border (D). Echocardiography demonstrated encroachment of the stent on the mitral valve.
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ing onto valvar apparatus of the heart, consideration
especially of the latter occurrence must be given in
selecting patients for self-expandable stent implantation.
Late complications. Significant neointimal ingrowth oc-
curred at an alarmingly high incidence of 28% (7/25) at a
mean follow-up duration of 8.1 months in this study. This
is in sharp contrast with the experience of Palmaz stents
where the incidence of significant restenosis was only 1.5 to
3% (2,4,13). Previous experimental studies in animals,
however, failed to show differences in neointimal thickness
in the stented arteries for the two types of stents (14,15).
Similar patency rate of the two stents in the iliac system was
demonstrated in another multicenter adult clinical trial (16).
What has been shown to be different, however, was the
delay in maturation of the neointimal growth of the Wall-
stent when compared with the Palmaz stent in canine iliac
and femoral arteries (14). A recent report further suggested
that the Wallstents placed in transjugular intrahepatic
portosystemic shunts were more thrombogenic than Palmaz
stents (17). Differences in maturation and thrombogenicity
may be related to the design of the stent, woven mesh with
expanding radial force (Wallstent) versus that of rigid
slotted tubes with smooth and even surface (Palmaz).
Alternatively, regions of the self-expanding stent might not
be adhering close enough to the luminal wall of the vessel,
predisposing to friction, abrasion, inflammation and ulti-
mately neointimal proliferation. The possibility of chronic
friction would persist despite the use of antiplatelet therapy.
Perhaps active “fixing” of the Wallstent onto the vessel by
balloon dilation might reduce this friction and abrasion.
Additionally, we observed that a smaller Wallstent and a
longer period of implantation before restudy were risk
factors relating to the development of significant neointimal
proliferation. A further problem in the use of the self-
expandable stent is that one could not use an oversized
balloon to dilate the stent or the stented lesion which
restenosed. The maximum diameter of the balloon chosen
could only be that of the size of the original stent placed (5).
This has resulted in suboptimal expansion of the restenosis
related to neointimal proliferation in our patients. This
could be a major drawback when compared with the Palmaz
stent, which allows the use of an oversized balloon to dilate
its restenotic region (4), with further advantage of the latter
to accommodate the growth of the child.
The unyielding design of the Wallstents for overdila-
tion when used in children who are actively growing has
always been a concern. Implantation of an over-sized
Figure 3. Patient with tetralogy of Fallot underwent stenting of
right pulmonary artery stenosis. Follow-up catheterization at 8
months demonstrated recurrent stenosis of the right pulmonary
artery secondary to neointimal proliferation. The stent (14 mm)
remains fully expanded (arrows).
Table 2. Angiographic and Hemodynamic Data Immediately After Stent Implantation and at
Follow-up Catheterization Restudy
Immediate
Poststenting
At
Restudy
p
Value
Diameter (mm)
Arterial stenoses (n 5 16) 7.6 6 2.1 6.5 6 3.1 NS
Venous stenoses (n 5 3) 7.5 6 0.5 4.5 6 2.2 NS
Gradient (mm Hg)
Systolic gradient across arterial stenoses
(n 5 13)
10.6 6 10.3 17.8 6 15.1 0.02
Mean gradient across venous stenoses
(n 5 3)
0.9 6 1 3.0 6 2.3 NS
Systolic right ventricular pressure after
pulmonary arterial stenting (n 5 11)
57.5 6 16.2 59.5 6 14.1 NS
Right ventricular to systemic systolic pressure
ratio after pulmonary arterial stenting (n 5 11)
0.59 6 0.15 0.6 6 0.13 NS
Difference in the total number (n) is related to (1) placement of more than one stent in two patients, (2) complete occlusion of
the vessel lumen in one patient, and (3) assessment of the right ventricular pressure only in those after right ventricular outflow
tract reconstruction.
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self-expanding stent would pose the risks of stimulating
neointimal growth, vessel erosion and aneurysm forma-
tion (3,18). As Wallstents could not be overdilated
beyond the preset limits, balloon dilatation in our pa-
tients was limited to those with suboptimal self-
expansion after initial deployment or those complicated
by significant intraluminal ingrowth. The results for the
latter circumstance were not so rewarding.
Study limitations. A major limitation of this study was the
relatively small number of patients involved. Without prior
knowledge on the long-term effect of this self-expandable
stent, we have limited its application to patients who would
obviously benefit from the simple and easy deployment. The
pooling of the results from two centers helped to expand the
experience and add weight to the conclusion. Indeed, the
similar occurrence of neointimal proliferation and delayed
migration of stents in the two centers eliminated significant
technical errors introduced from one specific center. Ac-
cepting that our duration of follow-up was relatively short
(longest was 42 months), we felt that the incidence of
neointimal proliferation was alarmingly high for this
intermediate-term result and were compelled to report this
without further delay. If, indeed, increased thrombogenicity
and delayed maturation of the neointima were intrinsic
properties related to the self-expanding Wallstent, longer
term follow-up could see a higher incidence of neointimal
proliferation. While the definition of significant neointimal
proliferation was arbitrarily set at .30% reduction of the
original expanded luminal diameter, this reduction could
result in significant impairment of perfusion or hemody-
namic disturbance (1). We felt that this arbitrary cutoff was
justified.
Conclusions. On the whole, three major issues of the
self-expanding Wallstent appear formidable at present.
First, the significant degree of neointimal ingrowth with
unsatisfactory response to balloon dilatation negates the
initial increase in vascular diameter. Second, the failure to
keep pace with growth limits its use in a young child. Third,
the possibility of distal migration demands careful selection
of suitable candidates. As a word of caution for those centers
planning to initiate stent placement, although it would be
tempting to use self-expandable Wallstents for their ease of
deployment, one should be fully aware of these important
limitations. The use of the self-expanding Wallstents
should be reserved for adolescents and adults in whom
Palmaz stent implantation would not be feasible and larger
caliber Wallstents could be implanted.
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